Annual Total Liabilities
$86.35 M
-$336.43 M-79.58%
December 31, 2023
Summary
- As of February 8, 2025, SLRN annual total liabilities is $86.35 million, with the most recent change of -$336.43 million (-79.58%) on December 31, 2023.
- During the last 3 years, SLRN annual total liabilities has fallen by -$58.01 million (-40.18%).
- SLRN annual total liabilities is now -79.58% below its all-time high of $422.79 million, reached on December 31, 2022.
Performance
SLRN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$90.03 M
+$6.51 M+7.79%
September 30, 2024
Summary
- As of February 8, 2025, SLRN quarterly total liabilities is $90.03 million, with the most recent change of +$6.51 million (+7.79%) on September 30, 2024.
- Over the past year, SLRN quarterly total liabilities has increased by +$3.68 million (+4.26%).
- SLRN quarterly total liabilities is now -79.63% below its all-time high of $441.87 million, reached on March 31, 2023.
Performance
SLRN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SLRN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.6% | +4.3% |
| 3 y3 years | -40.2% | -79.6% |
| 5 y5 years | -40.2% | -79.6% |
SLRN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.6% | at low | -79.6% | +164.3% |
| 5 y | 5-year | -79.6% | at low | -79.6% | +164.3% |
| alltime | all time | -79.6% | at low | -79.6% | +164.3% |
Acelyrin Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $90.03 M(+7.8%) |
| Jun 2024 | - | $83.52 M(+56.4%) |
| Mar 2024 | - | $53.42 M(-38.1%) |
| Dec 2023 | $86.35 M | $86.35 M(+26.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $68.11 M(+100.0%) |
| Jun 2023 | - | $34.06 M(-92.3%) |
| Mar 2023 | - | $441.87 M(+4.5%) |
| Dec 2022 | $422.79 M(+192.9%) | $422.79 M |
| Dec 2021 | $144.36 M | - |
FAQ
- What is Acelyrin annual total liabilities?
- What is the all time high annual total liabilities for Acelyrin?
- What is Acelyrin annual total liabilities year-on-year change?
- What is Acelyrin quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acelyrin?
- What is Acelyrin quarterly total liabilities year-on-year change?
What is Acelyrin annual total liabilities?
The current annual total liabilities of SLRN is $86.35 M
What is the all time high annual total liabilities for Acelyrin?
Acelyrin all-time high annual total liabilities is $422.79 M
What is Acelyrin annual total liabilities year-on-year change?
Over the past year, SLRN annual total liabilities has changed by -$336.43 M (-79.58%)
What is Acelyrin quarterly total liabilities?
The current quarterly total liabilities of SLRN is $90.03 M
What is the all time high quarterly total liabilities for Acelyrin?
Acelyrin all-time high quarterly total liabilities is $441.87 M
What is Acelyrin quarterly total liabilities year-on-year change?
Over the past year, SLRN quarterly total liabilities has changed by +$3.68 M (+4.26%)